Immunocytochemistry Assay, P16/Ki-67
QKF is the FDA product code for Immunocytochemistry Assay, P16/Ki-67, a class III device type, regulated under 21 CFR 864.1860. FDA's definition for this code reads: "The p16 and Ki-67 antibody cocktail is a qualitative immunocytochemical assay intended for the simultaneous detection of the p16INK4a (E6H4) and Ki-67 (274-11AC3V1) proteins in cervical specimens collected by a clinician". As of , FDA records hold no 510(k) clearances under this code and no recalls.
Classification record
- Product code
- QKF
- Device name
- Immunocytochemistry Assay, P16/Ki-67
- FDA definition
- The p16 and Ki-67 antibody cocktail is a qualitative immunocytochemical assay intended for the simultaneous detection of the p16INK4a (E6H4) and Ki-67 (274-11AC3V1) proteins in cervical specimens collected by a clinician.
- Regulation
- 21 CFR 864.1860
- Device class
- Class III
- Review panel
- Hematology
- Submission type
- PMA
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 0
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
